Nucleic Acid Amplification Testing Market Expected To Grow Steadily And Approach $22.09 Billion By 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Nucleic Acid Amplification Testing Market Expected To Scale Between 2026 And 2030?
The nucleic acid amplification testing market size has experienced substantial growth in recent years. This market is projected to expand from $11.03 billion in 2025 to $12.7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.2%. The historical growth in this sector is attributable to various factors, including infectious disease outbreaks, the expansion of clinical laboratories, the adoption of PCR technology, the implementation of public health screening programs, and declining assay costs.
The nucleic acid amplification testing market size is projected to experience swift expansion in the coming years, with an anticipated growth to $22.1 billion by 2030, driven by a compound annual growth rate (CAGR) of 14.8%. This growth in the forecast period can be primarily attributed to the rise of personalized medicine, an increasing demand for rapid diagnostic solutions, market expansion into emerging regions, advancements in technological miniaturization, and regulatory approvals for novel assays. Furthermore, major trends identified for the forecast period include the proliferation of rapid point-of-care molecular testing, the expansion of multiplex and syndromic panels, a growing adoption of isothermal amplification techniques, the growth in home-based and decentralized testing options, and an increasing focus on early disease detection.
Access Your Free Sample Report For In-Depth Market Analysis:
What Significant Factors Are Influencing The Nucleic Acid Amplification Testing Market Expansion?
The increasing prevalence of infectious diseases is projected to drive the expansion of the nucleic acid amplification testing market in the future. Infectious diseases are conditions originating from organisms that can spread from person to person either directly or indirectly through various methods, including physical contact, airborne transmission, tainted food or water, or vector-borne spread via insects. The rise in these diseases stems from factors such as antibiotic resistance, climate change, alterations in human behavior, and agricultural practices. Nucleic acid amplification testing (NAAT) offers swift and precise identification of infectious pathogens, facilitating prompt diagnosis and treatment, thereby assisting in curbing disease propagation. For instance, in October 2023, the Public Health Agency of Canada, a Canada-based government agency, stated that 4,216 hospitalizations linked to influenza were reported by participating provinces and territories during the 2022–2023 season. Consequently, the growing incidence of infectious diseases stimulates the growth of the nucleic acid amplification testing market.
Which Segment Categories Are Included In The Nucleic Acid Amplification Testing Market Segment Analysis?
The nucleic acid amplification testing market covered in this report is segmented –
1) By Type: Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems
2) By Amplification Method: Consumables, Instruments Or Systems
3) By Technology: Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests
4) By Application: Infectious Disease Testing, Oncology Testing, Genetic And Mitochondrial Disease Testing, Other Applications
5) By End-Use: Hospitals, Diagnostic Laboratories, Biotechnology Companies, Other End-Users
Subsegments:
1) By Target Amplification Systems: Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Nested PCR, Multiplex PCR, LAMP (Loop-Mediated Isothermal Amplification),
2) By Probe Amplification Systems: Nucleic Acid Sequence-Based Amplification (NASBA), Hybridization-Based Amplification, Branch Chain Amplification (BCA), Strand Displacement Amplification (SDA),
3) By Signal Amplification Systems: Enzyme-Linked Signal Amplification, Fluorescent Signal Amplification, Chemiluminescent Signal Amplification, Electrochemical Signal Amplification, Magnetic Particle-Based Signal Amplification
What Trends Are Affecting The Direction Of The Nucleic Acid Amplification Testing Market?
Leading companies in the nucleic acid amplification testing market are concentrating on developing innovative solutions, such as in vitro diagnostics (IVD) assays, to screen donated blood for CMV using nucleic acid amplification technology (NAT) under the IVDR. An IVD (in vitro diagnostic) assay is a test performed on biological samples to detect diseases, conditions, or infections outside the body in a laboratory setting. For instance, in June 2024, GFE, a Germany-based company, launched the PoET CMV. This IVD assay, PoET CMV, is specifically designed for the rapid and precise detection of cytomegalovirus (CMV) infections. Its distinct characteristics include high sensitivity and specificity, enabling early diagnosis and efficient monitoring of CMV in transplant patients and immunocompromised individuals. The assay leverages advanced molecular techniques to yield reliable results quickly, thereby supporting timely clinical decision-making.
Who Are The Active Companies Shaping The Nucleic Acid Amplification Testing Market?
Major companies operating in the nucleic acid amplification testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Eiken Chemical Co. Ltd., New England Biolabs Inc., TwistDx Limited, Bioneer Corporation
Get The Full Nucleic Acid Amplification Testing Market Report:
Which Region Is The Largest In The Nucleic Acid Amplification Testing Market?
North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Nucleic Acid Amplification Testing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Nucleic Acid Amplification Testing Market 2026, By The Business Research Company
Nucleic Acid Based Gene Therapy Market Report 2026
Nucleic Acid Isolation And Purification Market Report 2026
Automated Nucleic Acid Extraction Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
